| Source Date | Board Meeting Date | Details |
| 07 Nov 2025 | 12 Nov 2025 | Quarterly Results |
| 25 Sep 2025 | 30 Sep 2025 | Inter alia, to consider and approve:- 1. To take on record and deliberate upon the Letter of Intent (LOI) received from Telexcell Trade PTE LTD, Singapore, for a proposed acquisition of up to 25% equity stake in Welcure Drugs & Pharmaceuticals Ltd. at an indicative price of Rs.20 per share (a substantial premium over the prevailing market price). 2. To initiate the process of comprehensive due diligence in respect of the proposed transaction, including legal, financial, and regulatory aspects. 3. To consider authorizing the Company's representatives to negotiate and finalize the terms of definitive agreements, in alignment with Welcure's long-term growth strategy and compliance with applicable regulatory frameworks. 4. To explore enabling mechanisms for shareholder approval through postal ballot / general meeting, in line with SEBI, RBI, FEMA, and stock exchange requirements. 5. To deliberate on future strategic growth opportunities in global pharmaceutical and chemical exports, leveraging Telexcell's global trade network. |
| 11 Aug 2025 | 14 Aug 2025 | Quarterly Results & Inter alia to consider, approve and take on record the following matters: 1. Appointment of Branch Auditors. 2. Appointment/Re-appointment of Internal Auditors. 3. Appointment of Secretarial Auditor. 4. Directors Report for the financial year 2024-2025. 5. Allotment of Equity Shares under ESOS Scheme 2021. 6. Any other matter with the permission of the Chairperson. |
| 23 May 2025 | 28 May 2025 | Audited Results |
| 22 Apr 2025 | 25 Apr 2025 | Inter alia, to consider and approve:- 1.Allotment of Equity Shares under ESOS Scheme 2021. 2.Any other matter with the permission of Chairperson. |
| 29 Jan 2025 | 03 Feb 2025 | Quarterly Results |
| 18 Nov 2024 | 22 Nov 2024 | Rights Issue & Inter alia, to consider and transact the following businesses: (1) fund raising by way of equity shares or other securities through rights issue as may be permitted under applicable law(s), subject to such regulatory/statutory approvals as may be required and other related matters. |
| 29 Oct 2024 | 06 Nov 2024 | Quarterly Results |
| 06 Aug 2024 | 09 Aug 2024 | Quarterly Results |
| 05 Jul 2024 | 09 Jul 2024 | Inter alia, to consider and approve:- 1) Appointment of M/s. G. P. Sharma & Co., LLP, Chartered Accountants (FRN 100957W/W100247) as the Statutory Auditor of the Company, for a term of 5 years. 2) Appointment of Branch Auditors. 3) Directors? Report for the financial year 2023-2024. 4) Calendar of events for 49th Annual General Meeting of the Company. 5) Notice for convening 49th Annual General Meeting of the Company. 6) Allotment of Equity Shares under ESOS Scheme 2021 (First Tranche). 7) Any other matter with the permission of the Chairperson. |
| 24 May 2024 | 29 May 2024 | Audited Results |
| 18 Mar 2024 | 20 Mar 2024 | Inter alia, to consider various matters in connection with the Rights Issue, including the specific term of the Rights Issue, such as the determination of the Rights Issue price, rights entitlement ratio. |
| 07 Feb 2024 | 13 Feb 2024 | Quarterly Results |
| 24 Nov 2023 | 30 Nov 2023 | Rights Issue Inter alia, the proposal of fund raising by way of equity shares or other securities through rights issue as may be permitted under applicable law, subject to such regulatory/statutory approvals as may be required and other related matters |
| 10 Nov 2023 | 16 Nov 2023 | Preferential Issue of shares & Rights Issue & Issue Of Warrants |
| 01 Nov 2023 | 07 Nov 2023 | Preferential Issue of shares & Quarterly Results & Issue Of Warrants Inter-alia shall consider the proposal for raising of funds by issuance of equity shares / convertible bonds / debentures / warrants / preference shares / any other equity linked securities (?Securities?) by way of private placement, preferential issue or qualified institutions placement of Securities or any other method or mode as may be permitted under applicable laws, including the Companies Act, 2013 read with the rules notified thereunder and the Securities and Exchange Board of India (Issue of Capital and isclosure Requirements) Regulations, 2018, and to approve ancillary actions for the abovementioned fund raising subject to such regulatory / statutory approvals as may be required including approval of shareholders in this regard. |
| 20 Sep 2023 | 25 Sep 2023 | Inter alia, to consider:- 1) Reclassification of Authorized Share Capital and Consequent Amendment to Memorandum 2) Resignation of Mr. Ramamirtham Kannan as Independent Director 3) Reconstitution of Stakeholder's Relationship Committee 4) Notice for convening Extra Ordinary General Meeting of the Company 5) Any other matter with the permission of the Chairperson. |
| 07 Aug 2023 | 11 Aug 2023 | Quarterly Results |
| 20 Jun 2023 | 22 Jun 2023 | Inter alia consider, approve and take on record the following matters: 1) Appointment of M/s. G. P. Sharma & Co., LLP, Chartered Accountants (FRN 100957W/W100247) as the Statutory Auditor of the Company, for a term of one year. 2) Appointment of Internal Auditor for the financial year 2023-2024. 3) Appointment of Cost Auditor. 4) Reclassification of Authorized Share Capital and Consequent Amendment to memorandum. 5) Directors? Report for the financial year 2022-2023. 6) Calendar of events for 48 th Annual General Meeting of the Company. 7) Notice for convening 48 th Annual General Meeting of the Company. 8) Any other matter with the permission of the Chairperson. |
| 23 May 2023 | 29 May 2023 | Audited Results |
